SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial

Αναστασία Παπαδοπούλου, George Karavalakis, Efthymia Papadopoulou, Aliki Xochelli, Zoi Bousiou, Anastasios Vogiatzoglou, Penelope‐Georgia Papayanni, Aphrodite Georgakopoulou, Maria Giannaki, Fani Stavridou, Ioanna Vallianou, Maria Kammenou, Evangelia Varsamoudi, Vasiliki Papadimitriou, Chrysavgi Giannaki, Maria Sileli, Zoi Stergiouda, Garyfallia Stefanou, Georgia Kourlaba, George Gounelas, Maria Triantafyllidou, Eleni Siotou, Antonia Karaglani, Eleni Zotou, Georgia Chatzika, Anna Boukla, Apostolia Papalexandri, Maria-Georgia Koutra, Dimitra Apostolou, Georgia Pitsiou, Petros Morfesis, Michalis Doumas, Theodoros Karampatakis, Nikolaos Kapravelos, Militsa Bitzani, Μαρία Θεοδωρακοπούλου, Eva Serasli, Grigorios Georgolopoulos, Ioanna Sakellari, Asimina Fylaktou, Stavros Τryfon, Αchilles Anagnostopoulos, Evangelia Yannaki